| 215 | 1 | 76 |
| 下载次数 | 被引频次 | 阅读次数 |
<正>2020年我国第七次全国人口普查显示，60岁及以上人口为264 018 766人，占全国人口18.70%[1]。“十四五”期间，我国老年人口将突破3亿，中国将从轻度老龄化迈入中度老龄化，这也使得阿尔茨海默病(AD)相关认知障碍等与衰老有关的神经退行性疾病在疾病谱中的位置不断前移。一项全国性研究结果表明，2015年，我国AD患者的年治疗费用为1677.4亿美元，且这一费用成本逐年升高，预计至2050年将高达18 871.8亿美元，
Abstract：[1] 国家统计局，国务院第七次全国人口普查领导小组办公室.第七次全国人口普查公报(第五号)——人口年龄构成情况[J].中国统计，2021(5):10-11.
[2] Jia J,Wei C,Chen S,et al.The cost of Alzheimer’s disease in China and re-estimation of costs worldwide[J].Alzheimers Dement,2018,14(4):483-491.DOI:10.1016/j.jalz.2017.12.006.
[3] Thiebaut de Schotten M,Forkel SJ.The emergent properties of the connected brain[J].Science,2022,378(6619):505-510.DOI:10.1126/science.abq2591.
[4] Leergaard TB,Bjaalie JG.Atlas-based data integration for mapping the connections and architecture of the brain[J].Science,2022,378(6619):488-492.DOI:10.1126/science.abq2594.
[5] Yuan P,Zhang M,Tong L,et al.PLD3 affects axonal spheroids and network defects in Alzheimer’s disease[J].Nature,2022,612(7939):328-337.DOI:10.1038/s41586-022-05491-6.
[6] Sun Q,Zhang J,Li A,et al.Acetylcholine deficiency disrupts extratelencephalic projection neurons in the prefrontal cortex in a mouse model of Alzheimer’s disease[J].Nat Commun,2022,13(1):998.DOI:10.1038/s41467-022-28493-4.
[7] Zhang Z,Zhang Y,Yuwen T,et al.Hyper-excitability of corticothalamic PT neurons in mPFC promotes irritability in the mouse model of Alzheimer’s disease[J].Cell Rep,2022,41(11):111794.DOI:10.1016/j.celrep.2022.111794.
[8] Chen Y,Dang M,Zhang Z.Brain mechanisms underlying neuro-psychiatric symptoms in Alzheimer’s disease:a systematic review of symptom-general and -specific lesion patterns[J].Mol Neurodegener,2021,16(1):38.DOI:10.1186/s13024-021-00456-1.
[9] Jack CR Jr,Bennett DA,Blennow K,et al.NIA-AA research framework:toward a biological definition of Alzheimer’s disease[J].Alzheimers Dement,2018,14(4):535-562.DOI:10.1016/j.jalz.2018.02.018.
[10] Hansson O,Edelmayer RM,Boxer AL,et al.The Alzheimer’s Association appropriate use recommendations for blood biomarkers in Alzheimer’s disease[J].Alzheimers Dement,2022,18(12):2669-2686.DOI:10.1002/alz.12756.
[11] Teunissen CE,Verberk IMW,Thijssen EH,et al.Blood-based biomarkers for Alzheimer’s disease:towards clinical implementation[J].Lancet Neurol,2022,21(1):66-77.DOI:10.1016/S1474-4422(21)00361-6.
[12] Jiang Y,Zhou X,Ip FC,et al.Large-scale plasma proteomic profiling identifies a high-performance biomarker panel for Alzheimer’s disease screening and staging[J].Alzheimers Dement,2022,18(1):88-102.DOI:10.1002/alz.12369.
[13] Cai H,Pang Y,Wang Q,et al.Proteomic profiling of circulating plasma exosomes reveals novel biomarkers of Alzheimer’s disease[J].Alzheimers Res Ther,2022,14(1):181.DOI:10.1186/s13195-022-01133-1.
[14] Wang Y,Wang Y,Zhu J,et al.Systematic evaluation of urinary formic acid as a new potential biomarker for Alzheimer’s disease[J].Front Aging Neurosci,2022,14:1046066.DOI:10.3389/fnagi.2022.1046066.
[15] Lv S,Zhou X,Li Y,et al.The association between plasma α-synuclein (α-syn) protein,urinary Alzheimer-associated neuronal thread protein (AD7c-NTP),and apolipoprotein epsilon 4 (ApoE ε4) alleles and cognitive decline in 60 patients with Alzheimer’s disease compared with 28 age-matched normal individuals[J].Med Sci Monit,2021,27:e932998.DOI:10.12659/MSM.932998.
[16] Mahaman YAR,Embaye KS,Huang F,et al.Biomarkers used in Alzheimer’s disease diagnosis,treatment,and prevention[J].Ageing Res Rev,2022,74:101544．DOI:10.1016/j.arr.2021.101544.
[17] van Oostveen WM,de Lange ECM.Imaging techniques in Alzheimer’s disease:a review of applications in early diagnosis and longitudinal monitoring[J].Int J Mol Sci,2021,22(4):2110．DOI:10.3390/ijms22042110.
[18]徐俊，姜季委，石汉平．营养干预在阿尔茨海默病四级预防策略中的临床意义[J]．肿瘤代谢与营养电子杂志，2022,9(5):566-571．DOI:10.16689/j.cnki.cn11-9349/r.2022.05.006.
基本信息:
中图分类号:R749.1
引用信息:
[1]徐俊.认知障碍一体两翼的前沿可探索性[J].中华老年心脑血管病杂志,2023,25(08):785-787.
基金信息:
国家重点研发计划项目(2021YFC2500100,2021YFC 2500103); 国家自然科学基金(82071187,81870821)
2023-08-10
2023-08-10